EUVIMEDEUVIMED entdecken
Crossref

Niosomes in Improving Bioavailability and Reducing Toxicity Through Vesicular Carriers

Elakkiya Ms, Kamaleshwari Ms, Padma Preetha, Gayathri Ms, Sankar Mr

International Journal for Development of Science and Technology · 06.07.2026 · 2 · 1-12

DOI: 10.26524/ijdst.1.3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal for Development of Science and Technology, online erschienen am 06.07.2026. Verfasst von Elakkiya Ms und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Niosomes are non-ionic surfactant-based vesicular drug delivery that were created to address the drawbacks of traditionaldosage forms, specifically their poor bioavailability, instability, and systemic toxicity. It is constituted mostly of non-ionicsurfactants, cholesterol, and charge inducers, niosomes are capable of encapsulating both hydrophilic and hydrophobicmedicines within their water core and lipid bilayer, respectively. This review comprehensively discusses the composition,methods of preparation, and functional characteristics of niosomes, with a particular focus on their role in enhancingbioavailability and reducing drug-induced toxicity. Various preparation techniques, including ether injection, thin-film hydration,sonication, microfluidization, and transmembrane pH gradient methods, are highlighted. Examples including griseofulvin,anthocyanins, tretinoin, calcein, and antiviral medications support the critical examination of the use of niosomes in theadministration of antifungal, antiviral, anticancer, anti-inflammatory, neuroprotective, and dermatological treatments.Additionally, the effectiveness of niosomes in targeted drug delivery, controlled release, brain targeting, and reduction of organspecifictoxicity is emphasized. Clinical translation is still hindered by issues including stability, largescale manufacturing,sterilization, and regulatory concerns, notwithstanding its benefits. Further perspectives focus on stimuli-responsive, ligandtargeted,and combination drug-loaded niosomes to improve therapeutic outcomes. Overall, niosomes represent a promisingand versatile vesicular carrier system with significant potential in improving drug bioavailability, safety, and patient compliance.

Zitieren

APA

Ms, E., Ms, K., Preetha, P., Ms, G., & Mr, S. (2026). Niosomes in Improving Bioavailability and Reducing Toxicity Through Vesicular Carriers. International Journal for Development of Science and Technology, 2, 1-12. https://doi.org/10.26524/ijdst.1.3

Vancouver

Ms E, Ms K, Preetha P, Ms G, Mr S. Niosomes in Improving Bioavailability and Reducing Toxicity Through Vesicular Carriers. International Journal for Development of Science and Technology. 2026;2:1-12. doi:10.26524/ijdst.1.3

BibTeX
@article{Ms2026,
  author = {Ms, Elakkiya and Ms, Kamaleshwari and Preetha, Padma and Ms, Gayathri and Mr, Sankar},
  title = {Niosomes in Improving Bioavailability and Reducing Toxicity Through Vesicular Carriers},
  journal = {International Journal for Development of Science and Technology},
  year = {2026},
  volume = {2},
  pages = {1--12},
  doi = {10.26524/ijdst.1.3}
}
Kostenlos starten →